cate from SUNY Upstate Medical University. She is chairman of the national WOCN Certification Board Exam Committee and has authored several articles and lectured nationally on wound and ostomy care. She was named the 2008 Nurse of the Year by the United Ostomy Associations of America.
"As we honor patients through the Great Comebacks® program, we find that nurses continually play a vital role in helping our award winners to achieve their goals and be active members of their families and communities. We are proud to recognize Heidi Cross, who has been a resource and inspiration for so many individuals and families affected by digestive disease as well as her colleagues in the nursing profession," said Rolf Benirschke, Founder and Chairman, Great Comebacks® Program.
The Great Comebacks® Program is sponsored by ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, in partnership with the Crohn's & Colitis Foundation (CCFA), the United Ostomy Associations of America, Inc. (UOAA), the Intestinal Disease Education and Awareness Society (IDEAS), the Wound, Ostomy and Continence Nurses (WOCN) Society and the American Society of Colon and Rectal Surgeons (ASCRS).
"We are exceptionally delighted to honor Heidi Cross for her dedication to patients and her many achievements in ostomy care. She is a wonderful example of a nurse who regularly goes the extra mile to help patients achieve a full recovery and live a healthier life. She is a great example of the dedication that so many nurses in our field demonstrate every day," said Phyllis Bonham, PhD, MSN, RN, CWOCN, DPNAP, FAAN and President, WOCN Society.
About the Great Comebacks® ProgramNow in its third decade, the Great Comebacks® Program raises awareness of quality of life issues for people with Crohn's disease, ulcerative colitis, colorectal cancer and other diseases that can lead to ostomy surPage: 1 2 3 Related medicine technology :1
. Deloitte and Nonprofit Roundtable Host Real-World Disaster Exercise as Next Step in Developing Preparedness Plan for Greater Washington Region2
. Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery3
. Newly Approved HIV Drug Shows Great Promise4
. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL5
. BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients6
. Study Finds QIAGENs HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap7
. Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated8
. Intermezzo(R) 3.5 mg Achieves Greater Early Bioavailability Than Ambien(R) 10 mg Despite 65% Lower Dose9
. (RED) to Launch New Way for People to Get Music in Their Lives; Weekly Delivery of Great Music Helps to Save Lives in Africa10
. Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed Insulin11
. Bionovos VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness